TrialPloS one2022

Preventive ceftriaxone in patients at high risk of stroke-associated pneumonia. A post-hoc analysis of the PASS trial.

Wouter M Sluis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.